BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 37675298)

  • 1. Human aortic smooth muscle cell regulation by METTL3 via upregulation of m6A NOTCH1 modification and inhibition of NOTCH1.
    Yang J; Fang M; Yu C; Li Z; Wang Q; Li C; Wu J; Fan R
    Ann Transl Med; 2023 Aug; 11(10):350. PubMed ID: 37675298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.
    Meng QZ; Cong CH; Li XJ; Zhu F; Zhao X; Chen FW
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4328-4336. PubMed ID: 32373970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXM1 Participates in Scleral Remodeling in Myopia by Upregulating APOA1 Expression Through METTL3/YTHDF2.
    Xue M; Li B; Lu Y; Zhang L; Yang B; Shi L
    Invest Ophthalmol Vis Sci; 2024 Jan; 65(1):19. PubMed ID: 38190128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL3-regulated m6A modification impairs the decidualization of endometrial stromal cells by regulating YTHDF2-mediated degradation of FOXO1 mRNA in endometriosis-related infertility.
    Li X; Jin J; Long X; Weng R; Xiong W; Liang J; Liu J; Sun J; Cai X; Zhang L; Liu Y
    Reprod Biol Endocrinol; 2023 Oct; 21(1):99. PubMed ID: 37891533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer.
    Zhan L; Zhang J; Zhang JH; Liu XJ; Guo B; Chen JH; Tang ZH; Wang WY; Wang QY; Wei B; Cao YX
    Biomark Res; 2023 Apr; 11(1):43. PubMed ID: 37085864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3 promotes osteogenic differentiation of human umbilical cord mesenchymal stem cells by up-regulating m6A modification of circCTTN.
    Chen S; Duan X; He Y; Chen W
    Biosci Rep; 2024 Mar; 44(3):. PubMed ID: 38358895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL3-METTL14 complex induces necroptosis and inflammation of vascular smooth muscle cells via promoting N6 methyladenosine mRNA methylation of receptor-interacting protein 3 in abdominal aortic aneurysms.
    Li K; Zhang D; Zhai S; Wu H; Liu H
    J Cell Commun Signal; 2023 Sep; 17(3):897-914. PubMed ID: 36947363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3.
    Yi J; Peng F; Zhao J; Gong X
    Sci Rep; 2023 Oct; 13(1):17292. PubMed ID: 37828232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL3-Mediated N6-Methyladenosine Modification of lncRNA D26496 Suppresses the Proliferation and Migration of Schwann Cells after Sciatic Nerve Injury.
    He X; Zhang J; Guo Y; Yang X; Huang Y; Hao D
    Mol Neurobiol; 2023 May; 60(5):2413-2425. PubMed ID: 36656457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
    Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL3-mediated m6A modification increases Hspa1a stability to inhibit osteoblast aging.
    Wang Y; Chen Y; Xiao H; Liu Z; Liu X; Feng Z; Sheng X; Peng B; Ren X; Xu L; Teng F; Yi Z; Niu Y; Xiang D; Xia Y; Geng B
    Cell Death Discov; 2024 Mar; 10(1):155. PubMed ID: 38538596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3-Mediated N6-Methyladenosine Methylation Modifies Foxp3 mRNA Levels and Affects the Treg Cells Proportion in Peripheral Blood of Patients with Asthma.
    Fan L; Wu J; Wang H; Chen Q; He X; Wang Q; Yang Z
    Ann Clin Lab Sci; 2022 Nov; 52(6):884-894. PubMed ID: 36564065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. METTL3/YTHDF2 m6A axis mediates the progression of diabetic nephropathy through epigenetically suppressing PINK1 and mitophagy.
    Wang F; Bai J; Zhang X; Wang D; Zhang X; Xue J; Chen H; Wang S; Chi B; Li J; Ma X
    J Diabetes Investig; 2024 Mar; 15(3):288-299. PubMed ID: 38013600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.
    Yue B; Song C; Yang L; Cui R; Cheng X; Zhang Z; Zhao G
    Mol Cancer; 2019 Oct; 18(1):142. PubMed ID: 31607270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 downregulated vascular smooth muscle cell contractile proteins via ATG4B-mediated autophagy in thoracic aortic dissection.
    An Z; Qiao F; Lu Q; Ma Y; Liu Y; Lu F; Xu Z
    Heart Vessels; 2017 Dec; 32(12):1523-1535. PubMed ID: 28965202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m6A methyltransferase METTL3 facilitates multiple myeloma cell growth through the m6A modification of BZW2.
    Huang X; Yang Z; Li Y; Long X
    Ann Hematol; 2023 Jul; 102(7):1801-1810. PubMed ID: 37222774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. METTL3 Mediated MALAT1 m6A Modification Promotes Proliferation and Metastasis in Osteosarcoma Cells.
    Zhang Y; Xu Y; Qiu G; Luo Y; Bao Y; Lu J; Wang T; Wang Y
    Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37897586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma.
    Shi K; Sa R; Dou L; Wu Y; Dong Z; Fu X; Yu H
    Clin Epigenetics; 2023 Sep; 15(1):153. PubMed ID: 37742030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methyltransferase-like 3 aggravates endoplasmic reticulum stress in preeclampsia by targeting TMBIM6 in YTHDF2-dependent manner.
    Chen Y; Liu X; Li L; He X; Zheng F; Zhang Y; Gao H; Jin Z; Wu D; Wang Q; Tao H; Zhao Y; Liu W; Zou L
    Mol Med; 2023 Feb; 29(1):19. PubMed ID: 36747144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.